使用单药克拉屈滨治疗急性髓系白血病患者的分子复发。
Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.
机构信息
Department of Internal Medicine--Hemato-Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
出版信息
Am J Hematol. 2012 Feb;87(2):211-3. doi: 10.1002/ajh.22213. Epub 2011 Nov 4.
PMID:22052688
Abstract
Few studies have examined the treatment of molecular relapse in patients with acute myeloid leukemia (AML) using different treatment regimens. We describe for the first time in the literature experiences with administration of clofarabine monotherapy in the treatment of eight patients with AML with molecular relapse of the disease.
摘要
鲜有研究探讨过采用不同治疗方案治疗急性髓系白血病（AML）患者的分子复发问题。我们首次在文献中描述了用单药氯法拉滨治疗 8 例 AML 患者疾病分子复发的经验。
Zotero 插件